Purpose of Review

The study aims to evaluate the impact of COVID-19 on the delivery of health care and services to patients with chronic myeloid leukemia in low- and middle-income countries (LMICs) accessing treatment through The Max Foundation.

Recent Findings

An online survey was developed and sent via email to 527 partner physicians who had active patients under their care in July 2020, asking about the disruption of health services with multiple-choice answers or a five-point ordinal scale. Data from The Max Foundation’s Patient Access Tracking System (PATS®) was analyzed to evaluate program performance in 2020 compared with 2019. PATS® is used to track key patient information and supply chain data to ensure robust reporting, quality assurance, and safety. Among the 111 physicians who responded (20% response rate), 48% reported that someone on their team had contracted COVID-19. A total of 95 (85%) physicians reported at least some disruption of services to patients due to COVID-19, with 29 (26%) reporting frequent or complete disruption. Almost all physicians in the South Asia and Asia Pacific regions reported disruption (96% and 95%, respectively), compared with three quarters of physicians in Latin America. Institutions overcame challenges using a variety of solutions including telemedicine (60%), electronic prescriptions (45%), home delivery via courier services (31%), government workers (9%), and dispensation coordination with regional hospitals (14%).

Summary

The COVID-19 pandemic has disrupted services for CML physicians and patients worldwide. Overall, these disruptions did not appear to significantly affect The Max Foundation’s ability to provide patients with access to treatment, as novel approaches in telemedicine, supply chain, and dispensing, as well as provision of guidance and support for physicians were utilized to overcame disruption of services.

中文翻译：

---

低收入和中等收入国家 COVID-19 大流行期间的 CML 结果和护理提供

审查目的

该研究旨在评估 COVID-19 对通过 Max 基金会向低收入和中等收入国家 (LMIC) 的慢性粒细胞白血病患者提供医疗保健和服务的影响。

最近的发现

开发了一项在线调查，并通过电子邮件发送给 2020 年 7 月有活跃患者接受治疗的 527 名合作医生，通过多项选择答案或五分制量表询问医疗服务中断情况。分析了 Max Foundation 患者访问跟踪系统 (PATS®) 的数据，以评估 2020 年与 2019 年相比的项目绩效。PATS® 用于跟踪关键患者信息和供应链数据，以确保可靠的报告、质量保证和安全性。在 111 名做出回应的医生中（20% 的回应率），48% 的人报告说他们团队中有人感染了 COVID-19。共有 95 名 (85%) 医生报告说，由于 COVID-19，至少在一定程度上中断了对患者的服务，其中 29 名 (26%) 报告说经常或完全中断。与拉丁美洲四分之三的医生相比，南亚和亚太地区几乎所有的医生都报告了中断（分别为 96% 和 95%）。机构克服了使用各种解决方案的挑战，包括远程医疗 (60%)、电子处方 (45%)、通过快递服务送货上门 (31%)、政府工作人员 (9%) 以及与地区医院的配药协调 (14%)。

概括

COVID-19 大流行扰乱了全球 CML 医生和患者的服务。总体而言，这些中断似乎并未显着影响 Max 基金会为患者提供治疗机会的能力，因为远程医疗、供应链和配药方面的新方法以及为医生提供的指导和支持被用于克服中断服务。